PepGen Inc. (PEPG)

13.70 -0.26 (-1.86%) At close: 04:00PM EDT

PepGen Inc.

321 Harrison Avenue
8th Floor
Boston, MA 02118
United States
781 797 0979
https://pepgen.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 64

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. James G. McArthur Ph.D.	President, CEO, Treasurer, Secretary & Director	810.7k	N/A	1962
Mr. Noel P. Donnelly M.B.A.	Chief Financial Officer	604.24k	N/A	1970
Dr. Michelle L. Mellion M.D.	Senior Vice President of Clinical Development	507.81k	N/A	1976
Dr. Michael Gait Ph.D.	Founder & Scientific Advisory Board Member	N/A	N/A	N/A
Ms. Mary Beth DeLena J.D.	General Counsel & Secretary	N/A	N/A	1968
Mr. Niels Svenstrup Ph.D.	Senior Vice President of Chemistry, Manufacturing & Control	455.15k	N/A	1970
Ms. Emiko Bryant	Chief of Staff	N/A	N/A	N/A
Mr. Kyle Breidenstine	VP of Finance & Controller	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.

Corporate Governance

PepGen Inc.’s ISS Governance QualityScore as of May 1, 2024 is 8. The pillar scores are Audit: 7; Board: 6; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.